
特朗普政府正在考虑是否撤回提名海迪·奥弗顿博士出任食品药品监督管理局(FDA)局长,因有迹象表明她缺乏获得参议院批准所需的支持,知情人士透露。
The Trump administration has considered whether to withdraw the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid signs she lacks the support to get confirmed by the Senate, according to people familiar with the matter.
奥弗顿定于周三接受一个参议院委员会的表决,该委员会包括几位共和党议员,他们对她支持撤回疫苗接种建议、在放宽电子烟限制方面的作用以及她在堕胎政策上的立场表示担忧。
Overton is scheduled for a vote Wednesday by a Senate committee that includes several GOP lawmakers who have expressed concern about her support for rolling back vaccine recommendations, her role in a loosening restrictions on vapes and her stance on abortion policy.
知情人士称,白宫官员也在权衡是让她的提名在该委员会搁置,还是为她的提名发起强有力的支持。白宫和奥弗顿未回应置评请求。
White House officials are also weighing whether to allow her nomination to die in that committee or mount a robust support for her bid, these people said. The White House and Overton didn’t respond to requests for comment.
卫生与公众服务部部长小罗伯特·F·肯尼迪联系了参议员罗杰·马歇尔(共和党,堪萨斯州),商议由他接替奥弗顿的人选,一位知情人士透露。马歇尔是一名产科医生,最近在原本历来是共和党稳操胜券的参议员席位上败给了民主党人、牧师亚当·汉密尔顿。新闻网站Semafor较早报道称马歇尔正被考虑。马歇尔的一位发言人拒绝置评。
Health Secretary Robert F. Kennedy Jr. reached out to Sen. Roger Marshall (R., Kan.) about taking Overton’s place, a person familiar with the matter said. Marshall, an obstetrician, recently lost what was historically a safe Senate seat for Republicans to Democrat Adam Hamilton, a pastor. News website Semafor earlier reported that Marshall was under consideration. A spokeswoman for Marshall declined to comment.
马歇尔是参议院“让美国再次健康”核心小组的主席,但鉴于他支持除草剂草甘膦,未能赢得“让美国再次健康”运动的广泛支持。
Marshall is chair of the Senate’s Make America Healthy Again caucus, but hasn’t won broad support from the MAHA movement, given his support for the pesticide glyphosate.
奥弗顿目前协助领导白宫国内政策委员会,要想在参议院全体表决中获批,很可能需要参议院卫生委员会所有共和党人的支持。但路易斯安那州共和党参议员比尔·卡西迪在8月曾称奥弗顿在疫苗问题上的立场“几乎是取消资格的”,而缅因州共和党参议员苏珊·柯林斯和阿拉斯加州共和党参议员丽莎·穆尔科斯基此前也曾对特朗普政府在疫苗问题上的做法提出异议。
Overton, who currently helps lead the White House’s Domestic Policy Council, likely needs the support of every Republican on the Senate’s health panel to advance to a full Senate vote. But GOP Sen. Bill Cassidy of Louisiana in August called Overton’s stance on vaccines “almost disqualifying,” and Republicans Susan Collins of Maine and Lisa Murkowski of Alaska have previously taken issue with the Trump administration’s approach to vaccines.

知情人士透露,奥弗顿起草了特朗普总统8月的一项行政命令,建议儿童接种的疫苗种类减少。许多医学和科学组织称该命令在科学上毫无依据。
Overton drafted President Trump’s August executive order recommending children receive fewer immunizations, people familiar with the matter said. Many medical and scientific organizations have called the order scientifically unjustified.
卡西迪上周表示,他对奥弗顿的态度仍未决定,并在周日接受CBS《面对国家》节目采访时称仍有疑问。一位知情人士透露,截至周二他仍未决定,尽管他也担心食品药品监督管理局(FDA)由一系列代理局长领导。
Cassidy last week said that he was still undecided on Overton and on Sunday told CBS’s “Face the Nation” that he still had questions. He remained undecided Tuesday, said a person familiar with his thinking, though he is also worried about the FDA being led by a series of acting commissioners.
在9月的提名听证会上,柯林斯表达了对白宫接受调味电子烟的担忧。奥弗顿为FDA近期批准新型调味产品进行了辩护,称这些产品符合保护公众健康的法律标准。她还表示,自己与柯林斯一样,希望让儿童远离这些产品。
In Overton’s confirmation hearing in September, Collins voiced her concern about the White House’s embrace of flavored vaping. Overton responded by defending the FDA’s recent signoffs on new flavored products, saying they met the legal standard for protecting public health. She also said she shared Collins’ desire to keep children away from the products.
奥弗顿曾撰文称堕胎药“危险”,在反堕胎倡导者因特朗普政府批准了一种堕胎药的仿制药、同时拒绝收回对堕胎药的远程医疗获取渠道而感到失望之际,她也协助领导白宫国内政策工作。
Overton, who has written that the abortion pill is “dangerous,” has also helped lead domestic policy at the White House as antiabortion advocates have grown disappointed that the Trump administration approved a generic form of the abortion pill while declining to roll back telehealth access to the pills.
这引发了参议员乔什·霍利(共和党-密苏里州)的担忧,他反对广泛获取堕胎药。霍利周二对记者表示,尽管他早前有过担忧,但他对奥弗顿最近就美国食品药品监督管理局(FDA)目前正在进行的堕胎药安全性研究的计划给他的答复感到满意,尽管他仍在阅读她发来的内容。“我要求她做出的每一项承诺,她都做出了,”他说。
That had triggered concerns from Sen. Josh Hawley (R., Mo.), who opposes broad access to the pills. Hawley told reporters Tuesday that despite his earlier concerns, he is pleased with Overton’s recent answers to him on her plan for the FDA’s current study of abortion pill safety, though he is still reading what she sent. “Every commitment I asked her to give, she made,” he said.
“这是一个相当充实的答复。”在确认听证会上,奥弗顿在堕胎药问题上走钢丝,她表示该药已获FDA批准为安全有效,但同时表示她不会预判FDA目前正在进行的安全性研究的结果。
“It was a pretty fulsome response.”Overton walked a fine line on the abortion pill in her confirmation hearing, saying the pill has been approved by the FDA as safe and effective and yet saying she would not prejudge the outcome of the FDA’s current study on its safety.
特朗普在推掉他之前的FDA局长马蒂·马卡里博士后提名了奥弗顿。目前,FDA由律师凯尔·迪亚曼塔斯代理领导。知情人士透露,预计他将在年底前离任。知情人士称,如果他在奥弗顿或另一位提名人获确认前离任,官员们正考虑临时安排卫生与公众服务部高级顾问萨拉·布伦纳博士接任,她目前负责公共卫生事务,包括埃博拉病毒和大流行防备工作。
Trump nominated Overton after pushing out his previous FDA commissioner, Dr. Marty Makary. The FDA is currently being led by lawyer Kyle Diamantas on an acting basis. He is expected to leave his post by the end of the year, people familiar with the matter said. If he leaves before Overton or another nominee is confirmed, officials are considering temporarily installing Dr. Sara Brenner, a senior counselor at the Department of Health and Human Services who currently works on public health issues, including Ebola and pandemic preparedness, people familiar with the matter said.
周末,华盛顿特区各社区出现了反对奥弗顿提名的标语,上面写着:“拒绝海蒂·蒸汽顿。”自称是一群私人公民的“办公室健康”组织为这些标语买单,发言人珍妮·凯表示,并将它们张贴在阿拉斯加州安克雷奇、路易斯安那州巴吞鲁日和缅因州的几个城市。凯说,该组织担心奥弗顿在电子烟和疫苗问题上的立场,也担心她反对堕胎药。
Over the weekend, signs appeared around neighborhoods in Washington, D.C., opposing Overton’s nomination with the words: “Say no to Heidi Vaperton.”Health in Office, which identifies itself as a group of private citizens, paid for the signs, said spokeswoman Jenny Kay, and placed them in Anchorage, Alaska; Baton Rouge, La.; and cities in Maine. The group is worried about Overton’s stance on vaping and vaccines, Kay said, and is also concerned about her opposition to the abortion pill.
主要反堕胎组织“苏珊·B·安东尼生命美国”基于相反理由反对奥弗顿的提名。该组织称,她对堕胎药的反对力度不够,且未承诺收回远程医疗获取该药的途径。该组织希望联邦政府恢复要求堕胎药必须由医生当面配发的规定。
A major antiabortion group, Susan B. Anthony Pro-Life America, has come out against Overton’s nomination on the opposite grounds. It says she isn’t opposed enough to the abortion pill, and hasn’t committed to rolling back telehealth access to the pill. The group wants the federal government to restore requirements that the abortion pill be dispensed in person by a doctor.
“在奥弗顿博士的监管下,政府拒绝阻止堕胎药涌入反堕胎州,也拒绝阻止这些药物落入企图利用这些药物胁迫或毒害女性的掠夺者手中,”丹嫩费尔泽说。
“The administration, under Dr. Overton’s oversight, has refused to stop the flood of abortion drugs into pro-life states and into the hands of predators who seek to coerce or poison women with these drugs,” Dannenfelser said.
其他反堕胎活动人士则赞扬了奥弗顿的提名。美国卫生与公众服务部未回应置评请求。
Other antiabortion activists have praised Overton’s nomination. HHS didn’t respond to requests for comment.